Absence of TERT promoter mutations in primary melanocytic tumours of the central nervous system

Neuropathology and Applied Neurobiology

Volumn 40, Issue 6, 2014, Pages 794-797

  Gessi, Marco ^a   van de Nes, Johannes ^b   Griewank, Klaus ^b   Barresi, Valeria ^c   Buckland, Michael E ^f   Kirfel, Jutta ^a   Caltabiano, Rosario ^d   Hammes, Jennifer ^a   Lauriola, Libero ^e   Pietsch, Torsten ^a   Waha, Andreas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; BRAIN TUMOR; FEMALE; GENETICS; HUMAN; MALE; MELANOCYTE; MELANOMA; MIDDLE AGED; MUTATION; NEURILEMOMA; PATHOLOGY; PROMOTER REGION; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; MUTATION; NEURILEMMOMA; PROMOTER REGIONS, GENETIC; TELOMERASE; YOUNG ADULT;

EID: 84913592597     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12138     Document Type: Letter

References (10)

1. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science 2013; 339: 959-961
2. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013; 339: 957-959
3. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 2013; 110: 6021-6026
4. Griewank KG, Murali R, Schilling B, Scholz S, Sucker A, Song M, Süsskind D, Grabellus F, Zimmer L, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zeschnigk M. TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer 2013; 109: 497-501
5. Brat DJ, Perry A. Melanocytic lesions. In WHO Classification of Tumours of the Central Nervous System, 4th edn. Eds DN Louis, H Ohgaki, OD Wiestler, WK Cavenee. Lyon: IARC press, 2007; 181-183
6. Brat DJ, Giannini C, Scheithauer BW, Burger PC. Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 1999; 23: 745-754
7. Gessi M, Hammes J, Lauriola L, Dörner E, Kirfel J, Kristiansen G, zur Muehlen A, Denkhaus D, Waha A, Pietsch T. GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system. Neuropathol Appl Neurobiol 2013; 39: 417-425
8. Pedersen M, Küsters-Vandevelde HV, Viros A, Groenen PJ, Sanchez-Laorden B, Gilhuis JH, van Engen-van Grunsven IA, Renier W, Schieving J, Niculescu-Duvaz I, Springer CJ, Küsters B, Wesseling P, Blokx WA, Marais R. Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. Cancer Discov 2013; 3: 458-469
9. Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, Ibrahimpasic T, Ghossein RA, Fagin JA. Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab 2013; 98: 1562-1566
10. Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 2013; 20: 603-610